{"id":"W2800268644","doi":"","title":"血液凝固第XIII因子製剤の臨床 (5) 乾燥濃縮人血液凝固第XIII因子製剤(フィブロガミンP)が著効した術後リンパ漏の治療経験","year":2006,"lang":"ja","type":"article","venue":"Pharma Medica","topic":"Military Technology and Strategies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Philosophy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006111093,0.0003169441,0.0002016905,0.0005858134,0.001414126,0.00187694,0.0004281893,0.0008781993,0.03385101],"category_scores_gemma":[0.000970307,0.0002181692,0.0003821114,0.0004337847,0.001469985,0.001080821,0.0007005772,0.001451197,0.00929184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001186979,"about_ca_system_score_gemma":0.001639573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003714033,"about_ca_topic_score_gemma":0.002776219,"domain_scores_codex":[0.9996138,0.00004997393,0.00002700155,0.00008290194,0.0001585398,0.00006778615],"domain_scores_gemma":[0.9995806,0.00007282769,0.00006570028,0.0000397316,0.0001725994,0.00006865463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"case_report","study_design_scores_codex":[0.0005134991,0.0003359816,0.006705293,0.0008579104,0.0001101054,0.001355773,0.002027528,0.002547667,0.08895618,0.5648241,0.04263538,0.2891305],"study_design_scores_gemma":[0.00006271155,0.0008720502,0.009978771,0.0002319156,0.0001034701,0.001340743,0.001842716,0.001506977,0.1093864,0.08009854,0.7944589,0.0001168317],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.08964759,0.008223508,0.02969025,0.006531788,0.003808501,0.0004049902,0.000630061,0.0002393441,0.860824],"genre_scores_gemma":[0.4593765,0.007296894,0.02993326,0.002545781,0.001229801,0.0002559258,0.0006753487,0.00008278307,0.4986037],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03385101,"threshold_uncertainty_score":0.1132429,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01136388293402475,"score_gpt":0.2418517938321465,"score_spread":0.2304879108981218,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}